Article
In vitro, inhibition of mitogen-activated protein kinase pathways protects against bupivacaine- and ropivacaine-induced neurotoxicity.
Anesthesia and analgesia - 1 May 2008
Lirk Philipp, Haller Ingrid, Colvin Hans Peter, Lang Leopold, Tomaselli Bettina, Klimaschewski Lars, Gerner Peter
Abstract excerpt
BACKGROUND: Animal models show us that specific activation of the p38 mitogen-activated protein kinase (MAPK) may be a pivotal step in lidocaine neurotoxicity, but this has not been investigated in the case of two very widely used local anesthetics, bupivacaine and ropivacaine. We investigated the hypotheses that these drugs (A) are less neurotoxic than the prototype local anesthetic, lidocaine (B) are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
